China Regenerative Medicine International Ltd 08158
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- HKD 0.17
- Day Range
- HKD 0.19–0.22
- 52-Week Range
- HKD 0.09–1.15
- Bid/Ask
- HKD 0.18 / HKD 0.21
- Market Cap
- HKD 63.28 Mil
- Volume/Avg
- 341,075 / 26,559
Key Statistics
- Price/Earnings (Normalized)
- 27.87
- Price/Sales
- 0.68
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
China Regenerative Medicine International Ltd is an investment holding company engaged in the provision of healthcare products and services. Its reportable segments are Aesthetic medical and beauty services and Medical services. The vast majority of the company's revenue is derived from its Aesthetic medical and beauty services segment. Geographically, the People's Republic of China accounts for the majority of the revenue. It also has a presence in Hong Kong.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 46
- Website
- https://www.crmi.hk
Valuation
|
Metric
|
08158
|
|---|---|
Price/Earnings (Normalized) | 27.87 |
Price/Book Value | — |
Price/Sales | 0.68 |
Price/Cash Flow | — |
Price/Earnings
08158
Financial Strength
|
Metric
|
08158
|
|---|---|
Quick Ratio | 1.09 |
Current Ratio | 1.14 |
Interest Coverage | −109.02 |
Quick Ratio
08158
Profitability
|
Metric
|
08158
|
|---|---|
Return on Assets (Normalized) | −9.95% |
Return on Equity (Normalized) | −70.22% |
Return on Invested Capital (Normalized) | −16.97% |
Return on Assets
08158
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Rcgysdlm | Bdy | $586.3 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Nvtwrdk | Bkjbwl | $114.1 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Hhgcsgsh | Csfvqq | $109.5 Bil | |
MRNA
| Moderna Inc | Qxbfvzh | Lkwz | $54.0 Bil | |
BNTX
| BioNTech SE ADR | Hyjrtlf | Jvd | $22.2 Bil | |
ARGX
| argenx SE ADR | Zdcgktvnm | Znk | $21.6 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Tnbjwqrp | Ypwhqrl | $18.9 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Rqpwrycb | Fxgxtq | $14.7 Bil | |
INCY
| Incyte Corp | Physqcdm | Hfbwpj | $12.9 Bil | |
RPRX
| Royalty Pharma PLC Class A | Grnyjtshb | Xtsbr | $12.3 Bil |